Cargando…
An atlas of the bone marrow bone proteome in patients with dysproteinemias
Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammop...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140150/ https://www.ncbi.nlm.nih.gov/pubmed/37105956 http://dx.doi.org/10.1038/s41408-023-00840-8 |
_version_ | 1785033102599389184 |
---|---|
author | Ho, Matthew Dasari, Surendra Visram, Alissa Drake, Matthew T. Charlesworth, M. Cristine Johnson, Kenneth L. Pujari, Ganesh P. Jevremovic, Dragan Kourelis, Taxiarchis |
author_facet | Ho, Matthew Dasari, Surendra Visram, Alissa Drake, Matthew T. Charlesworth, M. Cristine Johnson, Kenneth L. Pujari, Ganesh P. Jevremovic, Dragan Kourelis, Taxiarchis |
author_sort | Ho, Matthew |
collection | PubMed |
description | Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM), newly diagnosed (NDMM), relapsed MM (RMM), and normal controls. Proteins involved in extracellular matrix (ECM) formation and immunity pathways were decreased in SMM and active MM. Among the proteins most decreased were immunoglobulins, type IV collagen, and TIMP3, suggesting increased immunoparesis and decreased ECM remodelling within trabecular bone. Proteins most increased in SMM/MM were APP (enhances osteoclast activity), ENPP1 (enhances bone mineralization), and MZB1 (required for normal plasmablast differentiation). Pathway analyses showed that proteins involved in gamma -carboxylation, a pathway implicated in osteocalcin function, osteoblast differentiation, and normal hematopoiesis, were also overexpressed in SMM/MM. This study is the first comprehensive proteomic atlas of the BM bone proteome in dysproteinemias. We identify new key proteins and pathways for MM bone disease and potentially impaired hematopoiesis, and show for the first time that gamma -carboxylation pathways are increased in the bone tissue of SMM/MM. |
format | Online Article Text |
id | pubmed-10140150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101401502023-04-29 An atlas of the bone marrow bone proteome in patients with dysproteinemias Ho, Matthew Dasari, Surendra Visram, Alissa Drake, Matthew T. Charlesworth, M. Cristine Johnson, Kenneth L. Pujari, Ganesh P. Jevremovic, Dragan Kourelis, Taxiarchis Blood Cancer J Article Multiple myeloma (MM) bone disease is a significant cause of morbidity but there is a paucity of data on the impact of malignant plasma cells on adjacent trabecular bone within the BM. Here, we characterize the proteome of trabecular bone tissue from BM biopsies of 56 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM), newly diagnosed (NDMM), relapsed MM (RMM), and normal controls. Proteins involved in extracellular matrix (ECM) formation and immunity pathways were decreased in SMM and active MM. Among the proteins most decreased were immunoglobulins, type IV collagen, and TIMP3, suggesting increased immunoparesis and decreased ECM remodelling within trabecular bone. Proteins most increased in SMM/MM were APP (enhances osteoclast activity), ENPP1 (enhances bone mineralization), and MZB1 (required for normal plasmablast differentiation). Pathway analyses showed that proteins involved in gamma -carboxylation, a pathway implicated in osteocalcin function, osteoblast differentiation, and normal hematopoiesis, were also overexpressed in SMM/MM. This study is the first comprehensive proteomic atlas of the BM bone proteome in dysproteinemias. We identify new key proteins and pathways for MM bone disease and potentially impaired hematopoiesis, and show for the first time that gamma -carboxylation pathways are increased in the bone tissue of SMM/MM. Nature Publishing Group UK 2023-04-28 /pmc/articles/PMC10140150/ /pubmed/37105956 http://dx.doi.org/10.1038/s41408-023-00840-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ho, Matthew Dasari, Surendra Visram, Alissa Drake, Matthew T. Charlesworth, M. Cristine Johnson, Kenneth L. Pujari, Ganesh P. Jevremovic, Dragan Kourelis, Taxiarchis An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title | An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title_full | An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title_fullStr | An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title_full_unstemmed | An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title_short | An atlas of the bone marrow bone proteome in patients with dysproteinemias |
title_sort | atlas of the bone marrow bone proteome in patients with dysproteinemias |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140150/ https://www.ncbi.nlm.nih.gov/pubmed/37105956 http://dx.doi.org/10.1038/s41408-023-00840-8 |
work_keys_str_mv | AT homatthew anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT dasarisurendra anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT visramalissa anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT drakematthewt anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT charlesworthmcristine anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT johnsonkennethl anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT pujariganeshp anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT jevremovicdragan anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT kourelistaxiarchis anatlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT homatthew atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT dasarisurendra atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT visramalissa atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT drakematthewt atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT charlesworthmcristine atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT johnsonkennethl atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT pujariganeshp atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT jevremovicdragan atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias AT kourelistaxiarchis atlasofthebonemarrowboneproteomeinpatientswithdysproteinemias |